UiPath (NASDAQ:PATH) posted its quarterly earnings data on Monday. The healthcare company reported $0.02 EPS for the quarter, beating the Zacks’ consensus estimate of ($0.05) by $0.07, Fidelity Earnings reports.
PATH opened at $69.00 on Wednesday. The company’s 50 day simple moving average is $54.63. UiPath has a twelve month low of $61.50 and a twelve month high of $90.00.
In related news, major shareholder East Fund 2013 Sca Sic Digital sold 2,100,400 shares of the stock in a transaction dated Friday, April 23rd. The shares were sold at an average price of $56.00, for a total value of $117,622,400.00. Also, CEO Daniel Dines sold 1,383,168 shares of the stock in a transaction dated Friday, April 23rd. The shares were sold at an average price of $56.00, for a total transaction of $77,457,408.00. Insiders sold a total of 5,011,241 shares of company stock valued at $280,629,496 over the last three months.
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. It develops UiPath Studio, a platform designed for RPA developers looking to build complex process automations with built-in governance capabilities, such as robust debugging tools, application programming interface automation, wizards to automate desktop or web applications, leverage custom code, and to integrate machine learning models into production workflows.
Further Reading: How to start trading in the forex market?
Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.